Thus, more research will be needed to understand GzA expression of CD4+ cyTreg in tumor models, determine the exact role of GzA and GzB for in vivo suppression, and evaluate CD4+ cyTreg anti-tumor potential in vivo. The gene discussed is CD4; the disease is neoplasm.